National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Tobramycin (TOBI Podhaler®) for the suppressive therapy of chronic pulmonary infection due to Ps aeruginosa in adults and children aged 6 years and older with CF.

Rapid Review

Commenced Completed Outcome
03/11/2010 November 2010 Full Pharmacoeconomic Evaluation not Recommended